Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Finan... (logy Division at Oregon Health State Uni...)

Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event

Date:10/4/2007

logy Division at Oregon Health State University.

Klara A. Dickinson, Senior Vice President, Regulatory Affairs and Compliance, was previously Vice President of Regulatory Affairs and Healthcare Compliance Officer at CoTherix, Inc. In this role, Ms. Dickinson led the filing of the NDA and label negotiations for the company's initial product, Ventavis(R) (iloprost) Inhalation Solution, an orphan drug. Prior to CoTherix, Ms. Dickinson was at Scios, Inc. as Associate Director of Regulatory Affairs where she was instrumental in securing regulatory approval for Natrecor(R) (nesiritide). From 1993 to 1997, she held several positions in the Quality Control and Regulatory Affairs departments at DEY Laboratories.

Kevin D. Weber, Senior Vice President Global Strategy and Operations, joined Hyperion Therapeutics from Ucyclyd Pharma, Inc, a subsidiary of Medicis Pharmaceuticals Corporation, where he was Vice President, General Manager. Mr. Weber's 22 years of pharmaceutical experience includes management positions with Rhone-Poulenc Rorer, VHA and Medicis Pharmaceuticals. He has successfully launched and managed several pharmaceutical brands in a variety of therapeutic areas including gastrointestinal (Maalox(R)), dermatology (Dynacin(R)), respiratory (Azmacort(R), Intal(R), and Orapred(R)) and rare metabolic disorders (AMMONUL and BUPHENYL(R) (sodium phenylbutyrate)).

Wayne B. Davis, PhD, MBA, Vice President, Clinical Operations joins Hyperion from SuperGen, Inc. where he most recently served as Senior Vice President, Clinical Research. During his tenure, Dr. Davis led the project team for SuperGen's first targeted anti-cancer therapeutic, MP470, resulting in the IND filing in March, 2007 and the initial enrollment of the first-in- human clinical study in July. Prior to SuperGen, Dr. Davis served as Vice President, Operations at PRA International, Executive Vice President Global Operational Services and Director General, North America at CroMedica, Inc. and Vi
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6
Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Speaker announces business members of IT Task Force
3. Doyle announces technology tax credits for Berbee
4. Doyle announces new energy, global warming policies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5

Post Your Comments:

Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Finan...(logy Division at Oregon Health State Uni...)